JPS61135586A - 発光蛋白アクアリン遺伝子を有するプラスミドおよび該発光蛋白の生合成法 - Google Patents
発光蛋白アクアリン遺伝子を有するプラスミドおよび該発光蛋白の生合成法Info
- Publication number
- JPS61135586A JPS61135586A JP17612584A JP17612584A JPS61135586A JP S61135586 A JPS61135586 A JP S61135586A JP 17612584 A JP17612584 A JP 17612584A JP 17612584 A JP17612584 A JP 17612584A JP S61135586 A JPS61135586 A JP S61135586A
- Authority
- JP
- Japan
- Prior art keywords
- aquarin
- plasmid
- photoprotein
- paq440
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000006830 Luminescent Proteins Human genes 0.000 title claims abstract description 19
- 108010047357 Luminescent Proteins Proteins 0.000 title claims abstract description 19
- 239000013612 plasmid Substances 0.000 title claims abstract description 17
- 230000015572 biosynthetic process Effects 0.000 title claims abstract description 7
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 title abstract 6
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 24
- 238000000034 method Methods 0.000 claims abstract description 23
- 241000242583 Scyphozoa Species 0.000 claims abstract description 16
- 239000002773 nucleotide Substances 0.000 claims abstract description 13
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 13
- 238000004519 manufacturing process Methods 0.000 claims abstract description 5
- 239000011575 calcium Substances 0.000 claims abstract 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract 2
- 229910052791 calcium Inorganic materials 0.000 claims abstract 2
- 150000001413 amino acids Chemical group 0.000 claims description 13
- 239000013598 vector Substances 0.000 claims description 10
- 241000588724 Escherichia coli Species 0.000 claims description 2
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 7
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 6
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 6
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 claims 6
- 235000001014 amino acid Nutrition 0.000 claims 5
- 229940024606 amino acid Drugs 0.000 claims 5
- 241000894006 Bacteria Species 0.000 claims 4
- 239000004475 Arginine Substances 0.000 claims 3
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 3
- 239000004471 Glycine Substances 0.000 claims 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 3
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 3
- 239000004472 Lysine Substances 0.000 claims 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 3
- 235000004279 alanine Nutrition 0.000 claims 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 3
- 235000009582 asparagine Nutrition 0.000 claims 3
- 229960001230 asparagine Drugs 0.000 claims 3
- 235000003704 aspartic acid Nutrition 0.000 claims 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 3
- 235000018417 cysteine Nutrition 0.000 claims 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 3
- 239000005547 deoxyribonucleotide Substances 0.000 claims 3
- 125000002637 deoxyribonucleotide group Chemical group 0.000 claims 3
- 235000013922 glutamic acid Nutrition 0.000 claims 3
- 239000004220 glutamic acid Substances 0.000 claims 3
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 claims 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 3
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 3
- 229960000310 isoleucine Drugs 0.000 claims 3
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 claims 3
- 229930182817 methionine Natural products 0.000 claims 3
- 244000005700 microbiome Species 0.000 claims 3
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims 3
- 125000002480 thymidyl group Chemical group 0.000 claims 3
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 claims 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 3
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 3
- 239000004474 valine Substances 0.000 claims 3
- 150000001412 amines Chemical class 0.000 claims 2
- 241001452028 Escherichia coli DH1 Species 0.000 claims 1
- 241001131785 Escherichia coli HB101 Species 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 claims 1
- 239000002299 complementary DNA Substances 0.000 abstract description 18
- 102000004169 proteins and genes Human genes 0.000 abstract description 8
- 108020004999 messenger RNA Proteins 0.000 abstract description 5
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 238000006243 chemical reaction Methods 0.000 description 12
- 108020004414 DNA Proteins 0.000 description 11
- 239000000203 mixture Substances 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- YHIPILPTUVMWQT-UHFFFAOYSA-N Oplophorus luciferin Chemical compound C1=CC(O)=CC=C1CC(C(N1C=C(N2)C=3C=CC(O)=CC=3)=O)=NC1=C2CC1=CC=CC=C1 YHIPILPTUVMWQT-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 229960000789 guanidine hydrochloride Drugs 0.000 description 2
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- FRFDXQWNDZMREB-ACZMJKKPSA-N Ala-Cys-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(O)=O FRFDXQWNDZMREB-ACZMJKKPSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- YZQCXOFQZKCETR-UWVGGRQHSA-N Asp-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 YZQCXOFQZKCETR-UWVGGRQHSA-N 0.000 description 1
- 108020004638 Circular DNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
- 102100029764 DNA-directed DNA/RNA polymerase mu Human genes 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- QCSFMCFHVGTLFF-NHCYSSNCSA-N Leu-Asp-Val Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O QCSFMCFHVGTLFF-NHCYSSNCSA-N 0.000 description 1
- DNDVVILEHVMWIS-LPEHRKFASA-N Met-Asp-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N DNDVVILEHVMWIS-LPEHRKFASA-N 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- OLWFDNLLBWQWCP-STQMWFEESA-N Tyr-Gly-Met Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O OLWFDNLLBWQWCP-STQMWFEESA-N 0.000 description 1
- ZRSZTKTVPNSUNA-IHRRRGAJSA-N Val-Lys-Leu Chemical compound CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(O)=O ZRSZTKTVPNSUNA-IHRRRGAJSA-N 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 108010083708 leucyl-aspartyl-valine Proteins 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17612584A JPS61135586A (ja) | 1984-08-24 | 1984-08-24 | 発光蛋白アクアリン遺伝子を有するプラスミドおよび該発光蛋白の生合成法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17612584A JPS61135586A (ja) | 1984-08-24 | 1984-08-24 | 発光蛋白アクアリン遺伝子を有するプラスミドおよび該発光蛋白の生合成法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11300089A Division JPH0296597A (ja) | 1989-05-02 | 1989-05-02 | 発光蛋白アクアリンの生合成法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61135586A true JPS61135586A (ja) | 1986-06-23 |
| JPH0251597B2 JPH0251597B2 (enrdf_load_stackoverflow) | 1990-11-07 |
Family
ID=16008107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP17612584A Granted JPS61135586A (ja) | 1984-08-24 | 1984-08-24 | 発光蛋白アクアリン遺伝子を有するプラスミドおよび該発光蛋白の生合成法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61135586A (enrdf_load_stackoverflow) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61224989A (ja) * | 1984-12-31 | 1986-10-06 | ユニヴア−シテイ・オブ・ジヨ−ジア・リサ−チ・フアウンデイシヨン・インコ−ポレイテツド | アポエクオリンを発現しうる組換えｄｎａベクタ− |
| JPS63102695A (ja) * | 1986-10-20 | 1988-05-07 | Chisso Corp | 大腸菌の菌体外分泌ベクタ−を用いる発光蛋白エクオリンの製造法 |
| US5139937A (en) * | 1987-11-18 | 1992-08-18 | Chisso Corporation | Process for producing apoaequorin |
| US7396655B2 (en) | 2005-03-30 | 2008-07-08 | Chisso Corporation | Method for enhancing activity of luciferase with fluorescence activity |
| US8710195B2 (en) | 2003-08-12 | 2014-04-29 | Jnc Corporation | Fluorescent proteins |
| US9678067B2 (en) | 2005-04-28 | 2017-06-13 | Jnc Corporation | Method for extending light-emitting time of calcium-binding photoprotein solution |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0435492U (enrdf_load_stackoverflow) * | 1990-07-24 | 1992-03-25 |
-
1984
- 1984-08-24 JP JP17612584A patent/JPS61135586A/ja active Granted
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61224989A (ja) * | 1984-12-31 | 1986-10-06 | ユニヴア−シテイ・オブ・ジヨ−ジア・リサ−チ・フアウンデイシヨン・インコ−ポレイテツド | アポエクオリンを発現しうる組換えｄｎａベクタ− |
| AU589930B2 (en) * | 1984-12-31 | 1989-10-26 | University Of Georgia Research Foundation, Inc., The | Recombinant dna vectors capable of expressing apoaequorin |
| JPH06217779A (ja) * | 1984-12-31 | 1994-08-09 | Univ Geogia | アポエクオリンをコードするヌクレオチド配列、該配列を含む組換えベクター及び該ベクターを含む組換え微生物 |
| JPS63102695A (ja) * | 1986-10-20 | 1988-05-07 | Chisso Corp | 大腸菌の菌体外分泌ベクタ−を用いる発光蛋白エクオリンの製造法 |
| US5139937A (en) * | 1987-11-18 | 1992-08-18 | Chisso Corporation | Process for producing apoaequorin |
| US8710195B2 (en) | 2003-08-12 | 2014-04-29 | Jnc Corporation | Fluorescent proteins |
| US7396655B2 (en) | 2005-03-30 | 2008-07-08 | Chisso Corporation | Method for enhancing activity of luciferase with fluorescence activity |
| US9678067B2 (en) | 2005-04-28 | 2017-06-13 | Jnc Corporation | Method for extending light-emitting time of calcium-binding photoprotein solution |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0251597B2 (enrdf_load_stackoverflow) | 1990-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1985000817A1 (en) | Microbial expression of interleukin ii | |
| JPH0789934B2 (ja) | 構造遺伝子の製造および発現 | |
| Alexandraki et al. | Evolution of α q-and β-tubulin genes as inferred by the nucleotide sequences of sea urichin cDNA clones | |
| PT871718E (pt) | Produção de carboxipeptidase b recombinante, activa sob o ponto de vista enzimático. | |
| JPH05244977A (ja) | 組換え蛋白質を活性化する方法 | |
| JPS61135586A (ja) | 発光蛋白アクアリン遺伝子を有するプラスミドおよび該発光蛋白の生合成法 | |
| WO2020187270A1 (zh) | 含有荧光蛋白片段的融合蛋白及其用途 | |
| JPH0570497A (ja) | アルフア−ヘリツクス３領域、アルフア−ヘリツクス２領域の変化、およびそれらの組み合わせ、並びに他の変異との組み合わせを有する成長ホルモン | |
| US7109015B2 (en) | Removal of N-terminal methionine from proteins by engineered methionine aminopeptidase | |
| FI93125B (fi) | Kasvuhormonia vapauttavan tekijän sekvenssin sisältävien hybridipolypeptidien ilmentäminen E. colissa | |
| EP0107710A1 (en) | The manufacture and expression of genes for calcitonin and polypeptide analogs thereof | |
| HU197939B (en) | Process for producing deoxyribonucleic acid, or its precursor, determining human growth hormone releasing factor | |
| IE914153A1 (en) | Somatotropins with alterations in the alpha-helix 1 region,¹and combinations with other mutations | |
| JPH06306100A (ja) | Ｖｉｐアナログ調製用融合蛋白、ｖｉｐアナログの製法並びにそのための遺伝子組換えプラスミド及び形質転換微生物 | |
| US6018037A (en) | DNA coding for (Leu13) motilin | |
| US20250188430A1 (en) | Pfu dna polymerase mutants with reverse transcriptase activity and their applications | |
| US5695952A (en) | Method for producing Leu13 !motilin | |
| JPH0683670B2 (ja) | デオキシリボ核酸 | |
| RU2143493C1 (ru) | Рекомбинантная плазмидная днк ppins16, кодирующая гибридный полипептид, содержащий проинсулин человека, рекомбинантная плазмидная днк ppins25, кодирующая гибридный полипептид, содержащий проинсулин человека, и штамм бактерий escherichia coli - продуцент гибридного полипептида, содержащего проинсулин человека | |
| JPS61502514A (ja) | 成長関連ホルモン | |
| JP3149216B2 (ja) | 転写活性増強因子ＰｉｔＩをコードするＤＮＡ | |
| CN118028263A (zh) | 一种dna聚合酶及其制备方法与应用、表达基因、表达载体及重组细胞 | |
| JPS60126088A (ja) | 新規ｄνａおよびその用途 | |
| JPS6115699A (ja) | 魚類の成長ホルモン遺伝子 | |
| JPH0759194B2 (ja) | Ｄｎａセグメント |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |